ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc (FDMT)

8.83
0.81
(10.10%)
Closed November 15 4:00PM
8.95
0.12
( 1.36% )
Pre Market: 8:46AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 500k1.25M298k240k20.2M-19k28k5k
Operating Income -26.49M-28.72M-30.11M-32.14M-13.97M-36.65M-38.14M-42.46M
Pre Tax Income -25.69M-27.38M-28.68M-29.62M-10.26M-32.28M-32.4M-34.95M
Net Income -25.69M-27.38M-28.68M-29.62M-10.26M-32.28M-32.4M-34.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -26.49M-28.72M-30.13M-32.13M-14.13M-36.66M-38.15M-42.51M
EBITDA -25.98M-27.71M-29.08M-31.06M-12.98M-35.55M-36.96M-41.26M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 14.13M6.99M13.61M18.04M3.13M20.72M
Operating Income -10.4M-50.76M-56.66M-71.33M-110.03M-112.87M
Pre Tax Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Net Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -1.863-9.52-2.125-2.213-3.295-2.359
EBIT -10.4M-50.81M-56.85M-71.45M-110.07M-113.05M
EBITDA -9.7M-49.76M-55.22M-69.81M-107.63M-108.66M